Moreover, the linker is sensitive to cysteine proteases that can facilitate efficient release of the payload inside cancer cells to ensure the killing effects.154 Another improvement of brentuximab vedotin is the use of the more potent cytotoxic payload, MMAE. The gene discussed is CTSB; the disease is cancer.